This inventor holds 1 USPTO granted patent and 1 published patent application, plus 2 CIPO patents and 2 EPO patents. Top assignee: Merck Patent Gmbh. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Hannes Koolman: Innovator in Cancer Treatment
Introduction
Hannes Koolman is a notable inventor based in Darmstadt, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds for cancer treatment. His innovative work focuses on thiazole derivatives, which have the potential to serve as effective kinase inhibitors.
Latest Patents
Hannes Koolman holds a patent for thiazole derivatives aimed at treating diseases such as cancer. The patent describes compounds of the formula Ia and Ib, where specific groups are defined in the claims. These compounds are recognized for their ability to act as kinase inhibitors, making them valuable in the treatment of tumors. He has 1 patent to his name.
Career Highlights
Koolman is currently employed at Merck Patent GmbH, where he continues to engage in groundbreaking research. His work at Merck has allowed him to collaborate with other experts in the field and contribute to the advancement of cancer therapies.
Collaborations
One of his notable coworkers is Timo Heinrich, with whom he collaborates on various projects related to medicinal chemistry and patent development.
Conclusion
Hannes Koolman is a dedicated inventor whose work in developing thiazole derivatives showcases his commitment to improving cancer treatment options. His contributions to the field are significant and continue to impact the medical community positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile